Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators

被引:23
作者
Seegers, Joachim [1 ]
Conen, David [2 ]
Jung, Klaus [3 ]
Bergau, Leonard [1 ]
Dorenkamp, Marc [4 ]
Luethje, Lars [1 ]
Sohns, Christian [1 ]
Sossalla, Samuel T. [1 ,5 ]
Fischer, Thomas H. [1 ,5 ]
Hasenfuss, Gerd [1 ,5 ]
Friede, Tim [3 ,5 ]
Zabel, Markus [1 ,5 ]
机构
[1] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Univ Basel Hosp, Dept Med, Basel, Switzerland
[3] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany
[4] Charite Campus Virchow Klinikum, Dept Med, Div Cardiol, Berlin, Germany
[5] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Gottingen, Germany
来源
EUROPACE | 2016年 / 18卷 / 08期
基金
瑞士国家科学基金会;
关键词
Cardiovascular mortality; Risk factors; Implantable cardioverter-defibrillator; Sex difference; Sudden cardiac death; SUDDEN CARDIAC DEATH; PRIMARY PREVENTION; HEART-FAILURE; GENDER-DIFFERENCES; CLINICAL-PRACTICE; RISK SCORE; THERAPY; WOMEN; IMPUTATION; SURVIVAL;
D O I
10.1093/europace/euv361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Implantable cardioverter-defibrillators (ICDs) have been shown to improve survival, although a considerable number of patients never receive therapy. Implantable cardioverter-defibrillators are routinely implanted regardless of sex. There is continuing controversy whether major outcomes differ between men and women. In this retrospective single-centre study, 1151 consecutive patients (19% women) undergoing ICD implantation between 1998 and 2010 were followed for mortality and first appropriate ICD shock over 4.9 +/- 2.7 years. Sex-related differences were investigated using multivariable Cox models adjusting for potential confounders. During follow-up, 318 patients died, a rate of 5.9% per year among men and 4.6% among women (uncorrected P = 0.08); 266 patients received a first appropriate ICD shock (6.3% per year among men vs. 3.6% among women, P = 0.002). After multivariate correction, independent predictors of all-cause mortality were age (hazard ratio, HR = 1.04 per year of age, 95% confidence interval (CI) [1.03-1.06], P < 0.001), left ventricular ejection fraction (HR = 0.98 per %, 95% CI [0.97-1.00], P = 0.025), renal function (HR = 0.99 per mL/min/1.73 m(2), 95% CI [0.99-1.00], P = 0.009), use of diuretics (HR = 1.81, 95% CI [1.29-2.54], P = 0.0023), peripheral arterial disease (HR = 2.21, 95% CI [1.62-3.00], P < 0.001), and chronic obstructive pulmonary disease (HR = 1.48, 95% CI [1.13-1.94], P = 0.029), but not sex. Female sex (HR = 0.51, 95% CI [0.33-0.81], P = 0.013), older age (HR = 0.98, 95% CI [0.97-0.99], P < 0.001), and primary prophylactic ICD indication (HR = 0.69, 95% CI [0.52-0.93], P = 0.043) were independent predictors for less appropriate shocks. Women receive 50% less appropriate shocks than men having similar mortality in this large single-centre population. These data may pertain to individually improved selection of defibrillator candidates using risk factors, e.g. sex as demonstrated in this study.
引用
收藏
页码:1194 / 1202
页数:9
相关论文
共 35 条
[21]   Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy [J].
Peterson, Pamela N. ;
Daugherty, Stacie L. ;
Wang, Yongfei ;
Vidaillet, Humberto J. ;
Heidenreich, Paul A. ;
Curtis, Jeptha P. ;
Masoudi, Frederick A. .
CIRCULATION, 2009, 119 (08) :1078-U30
[22]   Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies [J].
Pocock, Stuart J. ;
Ariti, Cono A. ;
McMurray, John J. V. ;
Maggioni, Aldo ;
Kober, Lars ;
Squire, Iain B. ;
Swedberg, Karl ;
Dobson, Joanna ;
Poppe, Katrina K. ;
Whalley, Gillian A. ;
Doughty, Rob N. .
EUROPEAN HEART JOURNAL, 2013, 34 (19) :1404-1413
[23]   Primary prevention with defibrillator therapy in women: Results from the Sudden Cardiac Death in Heart Failure Trial [J].
Russo, Andrea M. ;
Poole, Jeanne E. ;
Mark, Daniel B. ;
Anderson, Jill ;
Hellkamp, Anne S. ;
Lee, Kerry L. ;
Johnson, George W. ;
Domanski, Michael ;
Bardy, Gust H. .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2008, 19 (07) :720-724
[24]   Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis [J].
Santangeli, Pasquale ;
Pelargonio, Gemma ;
Dello Russo, Antonio ;
Casella, Michela ;
Bisceglia, Caterina ;
Bartoletti, Stefano ;
Santarelli, Pietro ;
Di Biase, Luigi ;
Natale, Andrea .
HEART RHYTHM, 2010, 7 (07) :876-882
[25]  
Therneau T, 2000, MODELING SURVIVAL DA, P44
[26]   A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death [J].
Tung, Roderick ;
Zimetbaum, Peter ;
Josephson, Mark E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) :1111-1121
[27]  
Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO
[28]  
2-I
[29]  
van Buuren S, 2011, J STAT SOFTW, V45, P1
[30]   Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients [J].
van der Heijden, Aafke C. ;
Thijssen, Joep ;
Borleffs, C. Jan Willem ;
van Rees, Johannes B. ;
Hoeke, Ulas ;
van der Velde, Enno T. ;
van Erven, Lieselot ;
Schalij, Martin J. .
HEART, 2013, 99 (17) :1244-1249